Myocarditis Heart Failure and Sudden Death Research Program
The Myocarditis Foundation (MF) awards funds to support research related to all forms of myocarditis research. The goal of MF’s research program is to advance medical knowledge on the disease and develop more accurate diagnostic methods and improved therapies with the goal of saving more lives.
Myocarditis Foundation Research Grants
The Myocarditis Foundation is currently accepting applications for Research Grants. Download and review the documents linked below.
Types of Proposals Sought
The Myocarditis Foundation (MF) accepts fellowship grant applications on an annual basis for innovative basic, clinical or translational research relevant to the cause or treatment of myocarditis. MF’s fellowship grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting preliminary data to help secure long-term funding by the National Institute of Health (NIH) and other major granting institutions. Funding is available at US $35,000 for salary only.
Grant award decisions are made through a peer review process by our Medical Advisory Board. Scientific excellence and relevance to myocarditis are the basic criteria for selecting the supported research project. The award is designed to support training and career development of physician-scientists in myocarditis research.
The MF research grant provides salary support for 1 year of full-time research. The stipend is $35,000. No additional funds for benefits, travel, or indirect costs, etc. are available.
Candidates may apply up to 10 years following receipt of an MD, PhD, or an equivalent degree and plan to perform the funded work in the United States or Canada, in order to apply for the Fellowship. All applicants must select a preceptor with a proven track record of research in myocarditis. In addition to providing a letter of recommendation, the preceptor is expected to assist in preparing the application. For applicants wishing advice in the selection of a preceptor, a list of potential preceptors is available from the MF.
The MF will issue a request for proposals in September of each year. The deadline for grant submission is December 15th with final award decisions made by December 31st. The research plan should be limited to 5 pages and must include the following: hypothesis, specific aims, background/significance, preliminary data, methods and expected results. The applicant should include a cover letter, supporting letter from the preceptor, and applicant and preceptor biographical sketches. Upon receipt of a signed letter of agreement from the selected candidate the MF will disburse the funds in installments during the research year.
A final report will be required upon completion of the research year. The Myocarditis Foundation reserves the right to cite the research in all/any of our printed materials and on our website. The Myocarditis Foundation must be acknowledged in all publications resulting from the research.
- MF Research Grant Overview (PDF, 59 KB)
- MF Research Grant Guidelines (PDF, 108 KB)
- MF Research Application Form (PDF, 76 KB)
AHA/Myocarditis Foundation Postdoctoral Fellowship
The Myocarditis Foundation has partnered with the American Heart Association (AHA) to establish an award for a postdoctoral fellow conducting research related to myocarditis. The award supports research proposing innovative basic, clinical or translational projects relevant to the etiology, pathophysiology, diagnosis, treatment, epidemiology and/or prevention of myocarditis.
Limited to Postdoctoral Fellows
Limited to the Postdoctoral Fellowship program.
The Myocarditis Foundation will provide 50% of the funding for one Postdoctoral Fellowship in the area of myocarditis research. The AHA will provide the other 50% of the funds for the selected award.
How to Apply
Visit the AHA Application Information Web site regarding application deadlines in your affiliate area.
The Myocarditis Foundation will select its designee from a list of meritorious fundable Postdoctoral Fellowship applications that are above the AHA payline, meaning that they are approved for funding.